Allergan plc (NYSE: AGN), a leading global pharmaceutical company today announced that the U.S. Food and Drug Administration (FDA) has accepted the company's resubmission of its Supplemental Biologics ...

Botox is a household name synonymous with wrinkle reduction and a youthful appearance. However, this powerful medication, derived from a purified neurotoxin, has a surprising array of uses that extend ...

Allergan plc, a global pharmaceutical leader, announced that the US Food and Drug Administration (FDA) approved the company's supplemental biologics application (sBLA) for Botox for the treatment of ...

Ipsen (GB:0MH6) announced an update on their ongoing clinical study. Study Overview: Ipsen recently completed a study titled A Multicentre, Interventional, Post-marketing, Randomised, Double-blind, ...

NORTH CHICAGO, Ill., Oct. 6, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced positive topline results from the Phase 2 ELATE trial evaluating the safety and efficacy of onabotulinumtoxinA ...

Botulinum toxin therapy has emerged as a pivotal treatment in the management of spasticity, a debilitating neuromuscular condition characterised by increased muscle tone and hyperactive reflexes. By ...

CHICAGO/WASHINGTON, Sept 1 (Reuters) - Allergan Inc has agreed to plead guilty and pay $600 million to resolve a federal probe of its marketing practices for the injectable wrinkle smoother Botox, the ...